LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 1 of 15: Cell count and relative growth within biological replicate 1. - Dataset (ID:20237)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Replicate | Assay Well | Timepoint | Timepoint Unit | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Relative Growth Rate After Treatment |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
MCF7 | TGX221 | 0.37 | uM | LJP5 | 1 | H22 | 72 | hr | 1235 | 4157 | 4156 | 1.0002 | 1.0003 |
MCF7 | TGX221 | 0.37 | uM | LJP5 | 2 | H22 | 72 | hr | 1235 | 4019 | 4156 | 0.9670 | 0.9530 |
MCF7 | TGX221 | 0.37 | uM | LJP5 | 3 | H22 | 72 | hr | 1235 | 4036 | 4156 | 0.9711 | 0.9589 |
MCF7 | Torin1 | 0.37 | uM | LJP6 | 1 | O16 | 72 | hr | 1235 | 1466 | 4156 | 0.3527 | 0.0790 |
MCF7 | Torin1 | 0.37 | uM | LJP6 | 2 | O16 | 72 | hr | 1235 | 1311 | 4156 | 0.3154 | 0.0259 |
MCF7 | Torin1 | 0.37 | uM | LJP6 | 3 | O16 | 72 | hr | 1235 | 1417 | 4156 | 0.3409 | 0.0622 |
MCF7 | Torin2 | 0.37 | uM | LJP5 | 1 | I22 | 72 | hr | 1235 | 1098 | 4156 | 0.2642 | -0.0470 |
MCF7 | Torin2 | 0.37 | uM | LJP5 | 2 | I22 | 72 | hr | 1235 | 1094 | 4156 | 0.2632 | -0.0484 |
MCF7 | Torin2 | 0.37 | uM | LJP5 | 3 | I22 | 72 | hr | 1235 | 1068 | 4156 | 0.2570 | -0.0573 |
MCF7 | Tozasertib | 0.37 | uM | LJP5 | 1 | B16 | 72 | hr | 1235 | 1509 | 4156 | 0.3631 | 0.0937 |
MCF7 | Tozasertib | 0.37 | uM | LJP5 | 2 | B16 | 72 | hr | 1235 | 1502 | 4156 | 0.3614 | 0.0913 |
MCF7 | Tozasertib | 0.37 | uM | LJP5 | 3 | B16 | 72 | hr | 1235 | 1439 | 4156 | 0.3462 | 0.0697 |
MCF7 | Trametinib | 0.37 | uM | LJP5 | 1 | P22 | 72 | hr | 1235 | 1927 | 4156 | 0.4637 | 0.2368 |
MCF7 | Trametinib | 0.37 | uM | LJP5 | 2 | P22 | 72 | hr | 1235 | 2327 | 4156 | 0.5599 | 0.3737 |
MCF7 | Trametinib | 0.37 | uM | LJP5 | 3 | P22 | 72 | hr | 1235 | 2125 | 4156 | 0.5113 | 0.3046 |
MCF7 | TWS119 | 0.37 | uM | LJP5 | 1 | M04 | 72 | hr | 1235 | 4256 | 4156 | 1.0240 | 1.0342 |
MCF7 | TWS119 | 0.37 | uM | LJP5 | 2 | M04 | 72 | hr | 1235 | 4061 | 4156 | 0.9771 | 0.9674 |
MCF7 | TWS119 | 0.37 | uM | LJP5 | 3 | M04 | 72 | hr | 1235 | 3761 | 4156 | 0.9049 | 0.8647 |
MCF7 | Vemurafenib | 0.37 | uM | LJP5 | 1 | C16 | 72 | hr | 1235 | 4496 | 4156 | 1.0818 | 1.1164 |
MCF7 | Vemurafenib | 0.37 | uM | LJP5 | 2 | C16 | 72 | hr | 1235 | 4101 | 4156 | 0.9867 | 0.9811 |
MCF7 | Vemurafenib | 0.37 | uM | LJP5 | 3 | C16 | 72 | hr | 1235 | 4360 | 4156 | 1.0490 | 1.0698 |
MCF7 | Withaferin A | 0.37 | uM | LJP5 | 1 | G16 | 72 | hr | 1235 | 1830 | 4156 | 0.4403 | 0.2036 |
MCF7 | Withaferin A | 0.37 | uM | LJP5 | 2 | G16 | 72 | hr | 1235 | 2076 | 4156 | 0.4995 | 0.2878 |
MCF7 | Withaferin A | 0.37 | uM | LJP5 | 3 | G16 | 72 | hr | 1235 | 1709 | 4156 | 0.4112 | 0.1622 |
MCF7 | Withaferin A | 0.37 | uM | LJP6 | 1 | G16 | 72 | hr | 1235 | 1769 | 4156 | 0.4256 | 0.1827 |